Nutriset SAS

Malaunay, France

Nutriset SAS

Malaunay, France

Time filter

Source Type

Arimond M.,University of California at Davis | Zeilani M.,Nutriset S.A.S. | Jungjohann S.,Global Alliance for Improved Nutrition | Brown K.H.,University of California at Davis | And 4 more authors.
Maternal and Child Nutrition | Year: 2015

The International Lipid-Based Nutrient Supplements (iLiNS) Project began in 2009 with the goal of contributing to the evidence base regarding the potential of lipid-based nutrient supplements (LNS) to prevent undernutrition in vulnerable populations. The first project objective was the development of acceptable LNS products for infants 6-24 months and for pregnant and lactating women, for use in studies in three countries (Burkina Faso, Ghana and Malawi). This paper shares the rationale for a series of decisions in supplement formulation and design, including those related to ration size, ingredients, nutrient content, safety and quality, and packaging. Most iLiNS supplements have a daily ration size of 20g and are intended for home fortification of local diets. For infants, this ration size is designed to avoid displacement of breast milk and to allow for dietary diversity including any locally available and accessible nutrient-dense foods. Selection of ingredients depends on acceptability of flavour, micronutrient, anti-nutrient and essential fatty acid contents. The nutrient content of LNS designed to prevent undernutrition reflects the likelihood that in many resource-poor settings, diets of the most nutritionally vulnerable individuals (infants, young children, and pregnant and lactating women) are likely to be deficient in multiple micronutrients and, possibly, in essential fatty acids. During ingredient procurement and LNS production, safety and quality control procedures are required to prevent contamination with toxins or pathogens and to ensure that the product remains stable and palatable over time. Packaging design decisions must include consideration of product protection, stability, convenience and portion control. © 2015 John Wiley & Sons, Ltd.


Adu-Afarwuah S.,University of Ghana | Lartey A.,University of Ghana | Zeilani M.,Nutriset SAS | Dewey K.G.,University of California at Davis
Maternal and Child Nutrition | Year: 2011

Inadequate micronutrient intake during pregnancy, lactation and infancy is a major problem in many developing countries. Lipid-based nutrient supplements (LNS) can improve micronutrient status, growth and development of infants, and also have potential to improve nutritional status of pregnant and lactating women. The objective of the study was to test the acceptability of LNS designed for infants (LNS-20gM) and pregnant or lactating women (LNS-P&L). Participants were infants (n=22, mean age=8 months) and pregnant or lactating women (n=24) attending routine services at a hospital in Ghana. Infants consumed 45g of a test meal consisting of one part LNS-20gM and three parts fermented maize porridge, while women consumed 50g of a similar test meal containing LNS-P&L instead. Participants also used their respective LNS at home for 14 days. Primary outcome was the proportion of the test meal consumed. On average, infants consumed 76.2% of the test meal [95% (confidence interval) CI: 65.7, 86.7], while women consumed 87.1% (95% CI: 82.6, 91.6). During the 14-day period, median daily consumption of LNS-20gM was 19.3g, very close to the recommended 20gd -1, while that of LNS-P&L was one sachet, as recommended. We conclude that LNS-20gM and LNS-P&L were well accepted. © 2010 Blackwell Publishing Ltd.


Adu-Afarwuah S.,University of Ghana | Lartey A.,University of Ghana | Okronipa H.,University of Ghana | Ashorn P.,University of Tampere | And 5 more authors.
American Journal of Clinical Nutrition | Year: 2015

Background: The International Lipid-Based Nutrient Supplements Project developed a small-quantity (20 g/d) lipid-based nutrient supplement (LNS) for pregnant and lactating women. Objective: We evaluated the effects of prenatal LNS supplementation on fetal growth. Design: In a community-based, partially double-blind, individually randomized controlled trial, 1320 women ≤20 wk pregnant received 60 mg Fe/400 mg folic acid (IFA), or 1-2 Recommended Dietary Allowances of 18 micronutrients, including 20 mg Fe (MMN), or LNS with the same micronutrients as the MMN group, plus 4 minerals and macronutrients contributing 118 kcal (LNS) daily until delivery. Fetal growth was compared across groups by using intention- to-treat analysis. The primary outcome was birth length. Results: This analysis included 1057 women (IFA = 349, MMN = 354, LNS = 354). Groups did not differ significantly in mean birth length, length-for-age z score (LAZ), head circumference, or percentage low birth length but differed in mean birth weight (P = 0.044), weight-for-age z score (WAZ; P = 0.046), and BMI-forage z score (BMIZ; P = 0.040), with a trend toward differences in low birth weight (P = 0.069). In pairwise comparisons, the LNS group had greater mean birth weight (+85 g; P = 0.040), WAZ (+0.19; P = 0.045), and BMIZ (+0.21; P = 0.035) and a lower risk of low birth weight (RR: 0.61, 95% CI: 0.39, 0.96; P = 0.032) than did the IFA group. The other group differences were not significant. The effect of intervention was modified by mother's parity, age, height, baseline hemoglobin, household food insecurity, and child sex, with parity being the most consistent modifier. Among primiparous women (IFA = 131; MMN = 110; LNS = 128), the LNS group had greater mean birth length (+0.91 cm; P = 0.001), LAZ (+0.47; P = 0.001), weight (+237 g; P < 0.001), WAZ (+0.56; P < 0.001), BMIZ (+0.52; P < 0.001), head circumference (0.50 cm; P = 0.017), and head circumference-for-age z score (+0.40; P = 0.022) than did the IFA group; similar differences were found when comparing the LNS and MMN groups among primiparous women, and no group differences were found among multiparous women. Conclusion: Prenatal LNS supplementation can improve fetal growth among vulnerable women in Ghana, particularly primiparous women. © 2015 American Society for Nutrition.


News Article | November 30, 2016
Site: www.newsmaker.com.au

the global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 25, 2016
Site: www.newsmaker.com.au

The global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 18, 2016
Site: www.newsmaker.com.au

Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. According to Persistence Market Research report, titled “Ready-to-use Therapeutic Food Market: Global Industry Analysis and Forecast, 2016–2024”, the global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 22, 2016
Site: www.newsmaker.com.au

Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. According to Persistence Market Research report, titled “Ready-to-use Therapeutic Food Market: Global Industry Analysis and Forecast, 2016–2024”, the global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 12, 2016
Site: www.newsmaker.com.au

In a new report titled “Ready-to-use Therapeutic Food Market: Global Industry Analysis and Forecast, 2016–2024”, Persistence Market Research delivers key insights on the global ready-to-use therapeutic food market and analyzes the key factors and trends impacting market performance over an eight-year forecast period (2016 – 2024). In 2015, the global ready-to-use therapeutic food market was valued at US$ 249.2 Mn, and this is estimated to increase to US$ 276.0 Mn by 2016 end, reflecting a Y-o-Y growth rate of 10.7%. In terms of value, the global ready-to-use therapeutic food market is expected to register a CAGR of 10.6% during the forecast period. Increasing government as well as NGO focus on the treatment of malnutrition is expected to drive revenue growth of the global ready-to-use therapeutic food market over the forecast period. Also, an increasing demand for drinkable ready-to-use therapeutic foods and rising global emergencies and disasters is expected to further fuel market growth. Demand for semi-solid paste therapeutic food products as a result of easy storage and distribution is fueling the demand for ready-to-use therapeutic food products to manage people suffering from severe acute malnutrition. Demand for ready-to-use drinkable therapeutic food is increasing with the government focusing on increasing the procurement of drinkable ready-to-use foods for small children. Rise in regional government bodies and global manufacturers planning to establish local manufacturing facilities is another major driving factor fueling the growth of the global ready-to-use therapeutic food market. However, increasing consumer/local government shift towards local ingredients and inconsistencies in ready-to-use therapeutic food milk products thereby creating a risk of contamination are factors likely to restrict market growth during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc The global ready-to-use therapeutic food market offers great opportunities for market players with UNICEF encouraging the domestic production of ready-to-use therapeutic foods. The global ready-to-use therapeutic food market is segmented on the basis of Product Type into Solid (Powder/Blends, Biscuits/Bar), Semi-solid Paste, and Drinkable Therapeutic Food; and on the basis of Region into North America, Asia Pacific (APAC), Europe, and Middle East & Africa (MEA). The Powder/Blends solid segment is estimated to create incremental $ opportunity of US$ 1.5 Mn between 2016 and 2024, registering a CAGR of 11.2% during the forecast period. The Biscuits/Bar solid segment is estimated to create incremental $ opportunity of US$ 7.8 Mn between 2016 and 2024, witnessing a CAGR of 8.7% during the forecast period. The Semi-solid Paste segment is expected to retain its dominance in the global ready-to-use therapeutic food market throughout the forecast period, with 90.7% value share by 2024. Among regions, Europe is estimated to account for a maximum revenue share of 62.0% of the global ready-to-use therapeutic food market by the end of 2016. The MEA market is expected to account for 19.1% market share of the global ready-to-use therapeutic food market by the end of 2016. The Europe ready-to-use therapeutic food market is estimated to be valued at US$ 171.0 Mn by 2016 end and is expected to increase to US$ 355.7 Mn by 2024 end, registering a CAGR of 9.6% during the forecast period. This report covers detailed profiles of key players operating in the global ready-to-use therapeutic food market – Insta Products (EPZ) Ltd., MANA, Nutrivita Foods Pvt Ltd., Power Foods Industries Ltd., Tabatchnick Fine Foods, HILINA Enriched Food Processing Center P.L.C., GC Rieber Compact AS, Diva Nutritional Products, Edesia, Inc., Nutriset, and InnoFasoSA. Ease of product availability, rising malnutrition population in developing nations, and an easy storage and distribution network are factors encouraging new players to venture into the global ready-to-use therapeutic food market. Established players in the global ready-to-use therapeutic food market are expanding production facilities and are focusing on product innovations, which is creating robust competition in the global ready-to-use therapeutic food market


News Article | December 6, 2016
Site: www.newsmaker.com.au

Persistence Market Research delivers key insights on the global ready-to-use therapeutic food market and analyzes the key factors and trends impacting market performance over an eight-year forecast period (2016 – 2024). In 2015, the global ready-to-use therapeutic food market was valued at US$ 249.2 Mn, and this is estimated to increase to US$ 276.0 Mn by 2016 end, reflecting a Y-o-Y growth rate of 10.7%. In terms of value, the global ready-to-use therapeutic food market is expected to register a CAGR of 10.6% during the forecast period. Increasing government as well as NGO focus on the treatment of malnutrition is expected to drive revenue growth of the global ready-to-use therapeutic food market over the forecast period. Also, an increasing demand for drinkable ready-to-use therapeutic foods and rising global emergencies and disasters is expected to further fuel market growth. Demand for semi-solid paste therapeutic food products as a result of easy storage and distribution is fueling the demand for ready-to-use therapeutic food products to manage people suffering from severe acute malnutrition. Demand for ready-to-use drinkable therapeutic food is increasing with the government focusing on increasing the procurement of drinkable ready-to-use foods for small children. Rise in regional government bodies and global manufacturers planning to establish local manufacturing facilities is another major driving factor fueling the growth of the global ready-to-use therapeutic food market. However, increasing consumer/local government shift towards local ingredients and inconsistencies in ready-to-use therapeutic food milk products thereby creating a risk of contamination are factors likely to restrict market growth during the forecast period. The global ready-to-use therapeutic food market offers great opportunities for market players with UNICEF encouraging the domestic production of ready-to-use therapeutic foods. The global ready-to-use therapeutic food market is segmented on the basis of Product Type into Solid (Powder/Blends, Biscuits/Bar), Semi-solid Paste, and Drinkable Therapeutic Food; and on the basis of Region into North America, Asia Pacific (APAC), Europe, and Middle East & Africa (MEA). The Powder/Blends solid segment is estimated to create incremental $ opportunity of US$ 1.5 Mn between 2016 and 2024, registering a CAGR of 11.2% during the forecast period. The Biscuits/Bar solid segment is estimated to create incremental $ opportunity of US$ 7.8 Mn between 2016 and 2024, witnessing a CAGR of 8.7% during the forecast period. The Semi-solid Paste segment is expected to retain its dominance in the global ready-to-use therapeutic food market throughout the forecast period, with 90.7% value share by 2024. Among regions, Europe is estimated to account for a maximum revenue share of 62.0% of the global ready-to-use therapeutic food market by the end of 2016. The MEA market is expected to account for 19.1% market share of the global ready-to-use therapeutic food market by the end of 2016. The Europe ready-to-use therapeutic food market is estimated to be valued at US$ 171.0 Mn by 2016 end and is expected to increase to US$ 355.7 Mn by 2024 end, registering a CAGR of 9.6% during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc This report covers detailed profiles of key players operating in the global ready-to-use therapeutic food market – Insta Products (EPZ) Ltd., MANA, Nutrivita Foods Pvt Ltd., Power Foods Industries Ltd., Tabatchnick Fine Foods, HILINA Enriched Food Processing Center P.L.C., GC Rieber Compact AS, Diva Nutritional Products, Edesia, Inc., Nutriset, and InnoFasoSA. Ease of product availability, rising malnutrition population in developing nations, and an easy storage and distribution network are factors encouraging new players to venture into the global ready-to-use therapeutic food market. Established players in the global ready-to-use therapeutic food market are expanding production facilities and are focusing on product innovations, which is creating robust competition in the global ready-to-use therapeutic food market.


News Article | November 28, 2016
Site: www.newsmaker.com.au

Global ready-to-use therapeutic food market was valued at US$ 249.2 Mn, and this is estimated to increase to US$ 276.0 Mn by 2016 end, reflecting a Y-o-Y growth rate of 10.7%. In terms of value, the global ready-to-use therapeutic food market is expected to register a CAGR of 10.6% during the forecast period. Increasing government as well as NGO focus on the treatment of malnutrition is expected to drive revenue growth of the global ready-to-use therapeutic food market over the forecast period. Also, an increasing demand for drinkable ready-to-use therapeutic foods and rising global emergencies and disasters is expected to further fuel market growth. Demand for semi-solid paste therapeutic food products as a result of easy storage and distribution is fueling the demand for ready-to-use therapeutic food products to manage people suffering from severe acute malnutrition. Demand for ready-to-use drinkable therapeutic food is increasing with the government focusing on increasing the procurement of drinkable ready-to-use foods for small children. Rise in regional government bodies and global manufacturers planning to establish local manufacturing facilities is another major driving factor fueling the growth of the global ready-to-use therapeutic food market. However, increasing consumer/local government shift towards local ingredients and inconsistencies in ready-to-use therapeutic food milk products thereby creating a risk of contamination are factors likely to restrict market growth during the forecast period. The global ready-to-use therapeutic food market offers great opportunities for market players with UNICEF encouraging the domestic production of ready-to-use therapeutic foods. The global ready-to-use therapeutic food market is segmented on the basis of Product Type into Solid (Powder/Blends, Biscuits/Bar), Semi-solid Paste, and Drinkable Therapeutic Food; and on the basis of Region into North America, Asia Pacific (APAC), Europe, and Middle East & Africa (MEA). The Powder/Blends solid segment is estimated to create incremental $ opportunity of US$ 1.5 Mn between 2016 and 2024, registering a CAGR of 11.2% during the forecast period. The Biscuits/Bar solid segment is estimated to create incremental $ opportunity of US$ 7.8 Mn between 2016 and 2024, witnessing a CAGR of 8.7% during the forecast period. The Semi-solid Paste segment is expected to retain its dominance in the global ready-to-use therapeutic food market throughout the forecast period, with 90.7% value share by 2024. Among regions, Europe is estimated to account for a maximum revenue share of 62.0% of the global ready-to-use therapeutic food market by the end of 2016. The MEA market is expected to account for 19.1% market share of the global ready-to-use therapeutic food market by the end of 2016. The Europe ready-to-use therapeutic food market is estimated to be valued at US$ 171.0 Mn by 2016 end and is expected to increase to US$ 355.7 Mn by 2024 end, registering a CAGR of 9.6% during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc This report covers detailed profiles of key players operating in the global ready-to-use therapeutic food market – Insta Products (EPZ) Ltd., MANA, Nutrivita Foods Pvt Ltd., Power Foods Industries Ltd., Tabatchnick Fine Foods, HILINA Enriched Food Processing Center P.L.C., GC Rieber Compact AS, Diva Nutritional Products, Edesia, Inc., Nutriset, and InnoFasoSA. Ease of product availability, rising malnutrition population in developing nations, and an easy storage and distribution network are factors encouraging new players to venture into the global ready-to-use therapeutic food market. Established players in the global ready-to-use therapeutic food market are expanding production facilities and are focusing on product innovations, which is creating robust competition in the global ready-to-use therapeutic food market.

Loading Nutriset SAS collaborators
Loading Nutriset SAS collaborators